Chronic lymphocytic leukaemia: Clonal origin in a committed B-lymphocyte progenitor

Area of Science:

• Hematology
• Oncology
• Genetics

Background:

• Chronic lymphocytic leukemia (C.L.L.) is a hematologic malignancy.
• Understanding the cellular origin of C.L.L. is crucial for disease classification and treatment.
• Previous studies suggested a clonal origin based on immunoglobulin markers.

Purpose of the Study:

• To investigate the cellular origin of C.L.L. using glucose-6-phosphate dehydrogenase (G.-6-P.D.) typing.
• To differentiate the cellular involvement in C.L.L. compared to other myeloproliferative syndromes.

Main Methods:

• Determined G.-6-P.D. types in isolated blood cell populations (B-lymphocytes, granulocytes, erythrocytes, platelets, T lymphocytes) and normal skin from two heterozygous C.L.L. patients.
• Analyzed G.-6-P.D. enzyme activity and types in different cell populations.

Main Results:

• Normal tissues and non-B-lymphocyte blood cells displayed both G.-6-P.D. types (A and B).
• C.L.L. B-lymphocyte populations showed a single G.-6-P.D. type or predominantly one type (95% activity).
• These findings support the clonal origin of C.L.L. in committed B-lymphocyte progenitors.

Conclusions:

• C.L.L. arises from a clonal expansion of committed B-lymphocyte progenitors.
• This contrasts with chronic myelocytic leukemia and other myeloproliferative disorders, which involve multipotent hematopoietic stem cells.
• G.-6-P.D. typing provides a valuable tool for elucidating the clonal nature of hematologic malignancies.